|
Jul 2
|
3 Giant Dividend Stocks to Buy to Shield Your Portfolio Now
|
|
Jul 2
|
The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney
|
|
Jul 2
|
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
|
|
Jul 2
|
Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?
|
|
Jul 2
|
Will AbbVie's Acquisition Spree Aid Pipeline Growth?
|
|
Jul 2
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
Jul 1
|
Top Stock Reports for Alphabet, AbbVie & Walt Disney
|
|
Jul 1
|
ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B
|
|
Jul 1
|
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
|
|
Jun 30
|
Sector Update: Health Care Stocks Advance Monday Afternoon
|
|
Jun 30
|
Stocks See Support as Signs of Trade Progress Boost Market Sentiment
|
|
Jun 30
|
AbbVie Agrees to Acquire Capstan Therapeutics for $2.1 Billion
|
|
Jun 30
|
AbbVie to buy Capstan for up to $2.1 billion in immunology push
|
|
Jun 30
|
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology
|
|
Jun 30
|
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
|
|
Jun 30
|
AbbVie to buy CAR-T developer Capstan in deal worth up to $2.1B
|
|
Jun 30
|
AbbVie to Host Second-Quarter 2025 Earnings Conference Call
|
|
Jun 29
|
3 Dividend Stocks to Double Up on Right Now
|
|
Jun 28
|
Those who invested in AbbVie (NYSE:ABBV) five years ago are up 126%
|
|
Jun 28
|
Got $500? 2 Healthcare Stocks to Buy and Hold Forever
|